Mon, March 27, 2023

Reni Benjamin Maintained (BCAB) at Buy with Decreased Target to $12 on, Mar 27th, 2023

Reni Benjamin of JMP Securities, Maintained "BioAtla, Inc." (BCAB) at Buy with Decreased Target from $17 to $12 on, Mar 27th, 2023.

Reni has made no other calls on BCAB in the last 4 months.



There are 3 other peers that have a rating on BCAB. Out of the 3 peers that are also analyzing BCAB, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Reiterated at Hold and Held Target at $8 on, Friday, March 24th, 2023


These are the ratings of the 2 analyists that currently disagree with Reni


  • Arthur He of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $17 on, Friday, March 24th, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $25 on, Friday, March 24th, 2023